▶ 調査レポート

ニコチンアミドアデニンジヌクレオチド(NAD)のグローバル市場インサイト・予測(~2028年)

が調査・発行した産業分析レポートです。ニコチンアミドアデニンジヌクレオチド(NAD)のグローバル市場インサイト・予測(~2028年) /  / 資料のイメージです。• レポートコード:
• 出版社/出版日: /
• レポート形態:、、ページ数はお問い合わせください。
• 納品方法:
• 販売価格(消費税別)
  ¥ 日本円の価格はお問い合わせください。 (0)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要

NAD+ is a coenzyme of a large number of REDOX enzymes in human body, which can be used as a direct template for drug design, or to design enzyme inhibitors or stimulants according to the structure of NAD+ to indirectly change the activity of NAD+ acting enzymes, or directly to inhibit the biosynthesis of NAD+.NAD can be used as an important adjunctive drug against aging.One of the most popular NAD supplements in modern biological research is NADH, a mitochondrial hormone whose role is to extend the life cycle of cells (anti-aging).With the development of research, the market of NAD will be infinite.
Market Analysis and Insights: Global Nicotinamide Adenine Dinucleotide (NAD) Market
Due to the COVID-19 pandemic, the global Nicotinamide Adenine Dinucleotide (NAD) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Pharmaceutical Grade accounting for % of the Nicotinamide Adenine Dinucleotide (NAD) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Dietary Supplement segment is altered to an % CAGR throughout this forecast period.
NAD+ is a coenzyme of a large number of REDOX enzymes in human body, which can be used as a direct template for drug design, or to design enzyme inhibitors or stimulants according to the structure of NAD+ to indirectly change the activity of NAD+ acting enzymes, or directly to inhibit the biosynthesis of NAD+.NAD can be used as an important adjunctive drug against aging.One of the most popular NAD supplements in modern biological research is NADH, a mitochondrial hormone whose role is to extend the life cycle of cells (anti-aging).With the development of research, the market of NAD will be infinite.
Global Nicotinamide Adenine Dinucleotide (NAD) Scope and Segment
Nicotinamide Adenine Dinucleotide (NAD) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Nicotinamide Adenine Dinucleotide (NAD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Pharmaceutical Grade
Food grade
Other
Segment by Application
Dietary Supplement
Pharmaceutical Industry
Other
By Company
EnzymeWorks
Bontac Bio-engineering
Hubei Widely Chemical Technology
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Nicotinamide Adenine Dinucleotide (NAD) Product Introduction
1.2 Market by Type
1.2.1 Global Nicotinamide Adenine Dinucleotide (NAD) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Pharmaceutical Grade
1.2.3 Food grade
1.2.4 Other
1.3 Market by Application
1.3.1 Global Nicotinamide Adenine Dinucleotide (NAD) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Dietary Supplement
1.3.3 Pharmaceutical Industry
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Nicotinamide Adenine Dinucleotide (NAD) Sales Estimates and Forecasts 2017-2028
2.2 Global Nicotinamide Adenine Dinucleotide (NAD) Revenue Estimates and Forecasts 2017-2028
2.3 Global Nicotinamide Adenine Dinucleotide (NAD) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Nicotinamide Adenine Dinucleotide (NAD) Sales by Region
2.4.1 Global Nicotinamide Adenine Dinucleotide (NAD) Sales by Region (2017-2022)
2.4.2 Global Sales Nicotinamide Adenine Dinucleotide (NAD) by Region (2023-2028)
2.5 Global Nicotinamide Adenine Dinucleotide (NAD) Revenue by Region
2.5.1 Global Nicotinamide Adenine Dinucleotide (NAD) Revenue by Region (2017-2022)
2.5.2 Global Nicotinamide Adenine Dinucleotide (NAD) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Nicotinamide Adenine Dinucleotide (NAD) Sales by Manufacturers
3.1.1 Global Top Nicotinamide Adenine Dinucleotide (NAD) Manufacturers by Sales (2017-2022)
3.1.2 Global Nicotinamide Adenine Dinucleotide (NAD) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nicotinamide Adenine Dinucleotide (NAD) in 2021
3.2 Global Nicotinamide Adenine Dinucleotide (NAD) Revenue by Manufacturers
3.2.1 Global Nicotinamide Adenine Dinucleotide (NAD) Revenue by Manufacturers (2017-2022)
3.2.2 Global Nicotinamide Adenine Dinucleotide (NAD) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Nicotinamide Adenine Dinucleotide (NAD) Revenue in 2021
3.3 Global Nicotinamide Adenine Dinucleotide (NAD) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Nicotinamide Adenine Dinucleotide (NAD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Nicotinamide Adenine Dinucleotide (NAD) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Nicotinamide Adenine Dinucleotide (NAD) Sales by Type
4.1.1 Global Nicotinamide Adenine Dinucleotide (NAD) Historical Sales by Type (2017-2022)
4.1.2 Global Nicotinamide Adenine Dinucleotide (NAD) Forecasted Sales by Type (2023-2028)
4.1.3 Global Nicotinamide Adenine Dinucleotide (NAD) Sales Market Share by Type (2017-2028)
4.2 Global Nicotinamide Adenine Dinucleotide (NAD) Revenue by Type
4.2.1 Global Nicotinamide Adenine Dinucleotide (NAD) Historical Revenue by Type (2017-2022)
4.2.2 Global Nicotinamide Adenine Dinucleotide (NAD) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Nicotinamide Adenine Dinucleotide (NAD) Revenue Market Share by Type (2017-2028)
4.3 Global Nicotinamide Adenine Dinucleotide (NAD) Price by Type
4.3.1 Global Nicotinamide Adenine Dinucleotide (NAD) Price by Type (2017-2022)
4.3.2 Global Nicotinamide Adenine Dinucleotide (NAD) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Nicotinamide Adenine Dinucleotide (NAD) Sales by Application
5.1.1 Global Nicotinamide Adenine Dinucleotide (NAD) Historical Sales by Application (2017-2022)
5.1.2 Global Nicotinamide Adenine Dinucleotide (NAD) Forecasted Sales by Application (2023-2028)
5.1.3 Global Nicotinamide Adenine Dinucleotide (NAD) Sales Market Share by Application (2017-2028)
5.2 Global Nicotinamide Adenine Dinucleotide (NAD) Revenue by Application
5.2.1 Global Nicotinamide Adenine Dinucleotide (NAD) Historical Revenue by Application (2017-2022)
5.2.2 Global Nicotinamide Adenine Dinucleotide (NAD) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Nicotinamide Adenine Dinucleotide (NAD) Revenue Market Share by Application (2017-2028)
5.3 Global Nicotinamide Adenine Dinucleotide (NAD) Price by Application
5.3.1 Global Nicotinamide Adenine Dinucleotide (NAD) Price by Application (2017-2022)
5.3.2 Global Nicotinamide Adenine Dinucleotide (NAD) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Nicotinamide Adenine Dinucleotide (NAD) Market Size by Type
6.1.1 North America Nicotinamide Adenine Dinucleotide (NAD) Sales by Type (2017-2028)
6.1.2 North America Nicotinamide Adenine Dinucleotide (NAD) Revenue by Type (2017-2028)
6.2 North America Nicotinamide Adenine Dinucleotide (NAD) Market Size by Application
6.2.1 North America Nicotinamide Adenine Dinucleotide (NAD) Sales by Application (2017-2028)
6.2.2 North America Nicotinamide Adenine Dinucleotide (NAD) Revenue by Application (2017-2028)
6.3 North America Nicotinamide Adenine Dinucleotide (NAD) Market Size by Country
6.3.1 North America Nicotinamide Adenine Dinucleotide (NAD) Sales by Country (2017-2028)
6.3.2 North America Nicotinamide Adenine Dinucleotide (NAD) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Nicotinamide Adenine Dinucleotide (NAD) Market Size by Type
7.1.1 Europe Nicotinamide Adenine Dinucleotide (NAD) Sales by Type (2017-2028)
7.1.2 Europe Nicotinamide Adenine Dinucleotide (NAD) Revenue by Type (2017-2028)
7.2 Europe Nicotinamide Adenine Dinucleotide (NAD) Market Size by Application
7.2.1 Europe Nicotinamide Adenine Dinucleotide (NAD) Sales by Application (2017-2028)
7.2.2 Europe Nicotinamide Adenine Dinucleotide (NAD) Revenue by Application (2017-2028)
7.3 Europe Nicotinamide Adenine Dinucleotide (NAD) Market Size by Country
7.3.1 Europe Nicotinamide Adenine Dinucleotide (NAD) Sales by Country (2017-2028)
7.3.2 Europe Nicotinamide Adenine Dinucleotide (NAD) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Nicotinamide Adenine Dinucleotide (NAD) Market Size by Type
8.1.1 Asia Pacific Nicotinamide Adenine Dinucleotide (NAD) Sales by Type (2017-2028)
8.1.2 Asia Pacific Nicotinamide Adenine Dinucleotide (NAD) Revenue by Type (2017-2028)
8.2 Asia Pacific Nicotinamide Adenine Dinucleotide (NAD) Market Size by Application
8.2.1 Asia Pacific Nicotinamide Adenine Dinucleotide (NAD) Sales by Application (2017-2028)
8.2.2 Asia Pacific Nicotinamide Adenine Dinucleotide (NAD) Revenue by Application (2017-2028)
8.3 Asia Pacific Nicotinamide Adenine Dinucleotide (NAD) Market Size by Region
8.3.1 Asia Pacific Nicotinamide Adenine Dinucleotide (NAD) Sales by Region (2017-2028)
8.3.2 Asia Pacific Nicotinamide Adenine Dinucleotide (NAD) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Nicotinamide Adenine Dinucleotide (NAD) Market Size by Type
9.1.1 Latin America Nicotinamide Adenine Dinucleotide (NAD) Sales by Type (2017-2028)
9.1.2 Latin America Nicotinamide Adenine Dinucleotide (NAD) Revenue by Type (2017-2028)
9.2 Latin America Nicotinamide Adenine Dinucleotide (NAD) Market Size by Application
9.2.1 Latin America Nicotinamide Adenine Dinucleotide (NAD) Sales by Application (2017-2028)
9.2.2 Latin America Nicotinamide Adenine Dinucleotide (NAD) Revenue by Application (2017-2028)
9.3 Latin America Nicotinamide Adenine Dinucleotide (NAD) Market Size by Country
9.3.1 Latin America Nicotinamide Adenine Dinucleotide (NAD) Sales by Country (2017-2028)
9.3.2 Latin America Nicotinamide Adenine Dinucleotide (NAD) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Nicotinamide Adenine Dinucleotide (NAD) Market Size by Type
10.1.1 Middle East and Africa Nicotinamide Adenine Dinucleotide (NAD) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Nicotinamide Adenine Dinucleotide (NAD) Revenue by Type (2017-2028)
10.2 Middle East and Africa Nicotinamide Adenine Dinucleotide (NAD) Market Size by Application
10.2.1 Middle East and Africa Nicotinamide Adenine Dinucleotide (NAD) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Nicotinamide Adenine Dinucleotide (NAD) Revenue by Application (2017-2028)
10.3 Middle East and Africa Nicotinamide Adenine Dinucleotide (NAD) Market Size by Country
10.3.1 Middle East and Africa Nicotinamide Adenine Dinucleotide (NAD) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Nicotinamide Adenine Dinucleotide (NAD) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 EnzymeWorks
11.1.1 EnzymeWorks Corporation Information
11.1.2 EnzymeWorks Overview
11.1.3 EnzymeWorks Nicotinamide Adenine Dinucleotide (NAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 EnzymeWorks Nicotinamide Adenine Dinucleotide (NAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 EnzymeWorks Recent Developments
11.2 Bontac Bio-engineering
11.2.1 Bontac Bio-engineering Corporation Information
11.2.2 Bontac Bio-engineering Overview
11.2.3 Bontac Bio-engineering Nicotinamide Adenine Dinucleotide (NAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bontac Bio-engineering Nicotinamide Adenine Dinucleotide (NAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bontac Bio-engineering Recent Developments
11.3 Hubei Widely Chemical Technology
11.3.1 Hubei Widely Chemical Technology Corporation Information
11.3.2 Hubei Widely Chemical Technology Overview
11.3.3 Hubei Widely Chemical Technology Nicotinamide Adenine Dinucleotide (NAD) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Hubei Widely Chemical Technology Nicotinamide Adenine Dinucleotide (NAD) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Hubei Widely Chemical Technology Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Nicotinamide Adenine Dinucleotide (NAD) Industry Chain Analysis
12.2 Nicotinamide Adenine Dinucleotide (NAD) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nicotinamide Adenine Dinucleotide (NAD) Production Mode & Process
12.4 Nicotinamide Adenine Dinucleotide (NAD) Sales and Marketing
12.4.1 Nicotinamide Adenine Dinucleotide (NAD) Sales Channels
12.4.2 Nicotinamide Adenine Dinucleotide (NAD) Distributors
12.5 Nicotinamide Adenine Dinucleotide (NAD) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Nicotinamide Adenine Dinucleotide (NAD) Industry Trends
13.2 Nicotinamide Adenine Dinucleotide (NAD) Market Drivers
13.3 Nicotinamide Adenine Dinucleotide (NAD) Market Challenges
13.4 Nicotinamide Adenine Dinucleotide (NAD) Market Restraints
14 Key Findings in The Global Nicotinamide Adenine Dinucleotide (NAD) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer